Healthcare - Biotechnology - NASDAQ - US
$ 170.74
-3.75 %
$ 4.91 B
Market Cap
96.46
P/E
Price Target
Average
22.26%
Revenue Forecast
Estimate
39.57%
EBIT
Estimate
--56.17%
Net Income
Estimate
25.86%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Krystal Biotech, Inc.
Wall Street analysts predict an average 1-year price target for KRYS of $209 , with forecasts ranging from a low of $204 to a high of $220 .
KRYS Lowest Price Target
Wall Street Target
204 USD
19.48%
KRYS Average Price Target
Wall Street Target
209 USD
22.26%
KRYS Highest Price Target
Wall Street Target
220 USD
28.85%
REVENUE FORECAST
Revenue Forecast Chart KRYS
EBIT FORECAST
EBIT Forecast Chart KRYS
NET INCOME FORECAST
Net Income Chart KRYS